{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:23:05Z","timestamp":1783200185935,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.gene.2021.146027","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T22:56:57Z","timestamp":1634597817000},"page":"146027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Meta-analysis for association of TNFA-308(G\u00a0>\u00a0A) SNP with vitiligo susceptibility"],"prefix":"10.1016","volume":"809","author":[{"given":"Prashant S.","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheedunnisa","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-0765","authenticated-orcid":false,"given":"Mitesh","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.gene.2021.146027_b0005","doi-asserted-by":"crossref","first-page":"e0240221","DOI":"10.1371\/journal.pone.0240221","article-title":"Tumor necrosis factor (TNF)-\u03b1- 308 G\/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis","volume":"15","author":"Abd El-Raheem","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2021.146027_b0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/CCID.S272970","article-title":"Effect of TNF-\u03b1 -308G\/A (rs1800629) Promoter Polymorphism on the Serum Level of TNF-\u03b1 Among Iraqi Patients with Generalized Vitiligo","volume":"13","author":"Ahmed","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.gene.2021.146027_b0015","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.4238\/2013.July.8.1","article-title":"Tumor necrosis factor-\u03b1 and -\u03b2 genetic polymorphisms as a risk factor in Saudi patients with vitiligo","volume":"12","author":"Al-Harthi","year":"2013","journal-title":"Genet. Mol. Res."},{"issue":"1","key":"10.1016\/j.gene.2021.146027_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ced.12446","article-title":"The combination of tumour necrosis factor-\u03b1 -308A and interleukin-10 -1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo","volume":"40","author":"Ayd\u0131ng\u00f6z","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.gene.2021.146027_b0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: A Review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.gene.2021.146027_b0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","article-title":"The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo","volume":"14","author":"Camara-Lemarroy","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.gene.2021.146027_b0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.gene.2021.146027_b0040","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","article-title":"Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population","volume":"169","author":"Dwivedi","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.gene.2021.146027_b0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized Vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"issue":"4","key":"10.1016\/j.gene.2021.146027_b0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejr.2017.04.008","article-title":"Clinical significance of tumor necrosis factor-\u03b1-863 C\/A and -1031 T\/C promoter polymorphisms in systemic lupus erythematosus patients: Relation to disease activity and damage","volume":"39","author":"El-Dakrony","year":"2017","journal-title":"Egypt. Rheumatol."},{"issue":"1","key":"10.1016\/j.gene.2021.146027_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-016-3197-y","article-title":"TNF-\u03b1 gene polymorphisms and expression","volume":"5","author":"El-Tahan","year":"2016","journal-title":"Springerplus"},{"issue":"8","key":"10.1016\/j.gene.2021.146027_b0060","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.onc.1202446","article-title":"Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation","volume":"18","author":"Englaro","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2021.146027_b0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4126","article-title":"A practical approach to the diagnosis and treatment of vitiligo in children","author":"Ezzedine","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.gene.2021.146027_b0070","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/exd.14157","article-title":"Decreased suppression of CD8+ and CD4+ T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins","volume":"29","author":"Giri","year":"2020","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.gene.2021.146027_b0075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/pcmr.12862","article-title":"Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients","volume":"33","author":"Giri","year":"2020","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.gene.2021.146027_b0080","doi-asserted-by":"crossref","first-page":"145295","DOI":"10.1016\/j.gene.2020.145295","article-title":"Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population","volume":"768","author":"Giri","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.gene.2021.146027_b0085","doi-asserted-by":"crossref","first-page":"101322","DOI":"10.1016\/j.genrep.2021.101322","article-title":"Genetic association of interleukin-4 VNTR polymorphism with susceptibility to rheumatoid arthritis in South Gujarat population","volume":"25","author":"Giri","year":"2021","journal-title":"Gene Reports"},{"key":"10.1016\/j.gene.2021.146027_b0090","author":"Han","year":"2020","journal-title":"JASP (Software)"},{"key":"10.1016\/j.gene.2021.146027_b0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2133.2012.11000.x","article-title":"Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo","volume":"167","author":"Imran","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.gene.2021.146027_b0100","doi-asserted-by":"crossref","first-page":"e0180958","DOI":"10.1371\/journal.pone.0180958","article-title":"A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat","volume":"12","author":"Jadeja","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2021.146027_b0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2017.06.005","article-title":"Tumor necrosis factor-alpha -863C\/A polymorphism is associated with Guillain-Barr\u00e9 syndrome in Bangladesh","volume":"310","author":"Jahan","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.gene.2021.146027_b0110","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2021.146027_b0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12291-019-00854-9","article-title":"Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C\/A single nucleotide polymorphism in the susceptibility to systemic lupus erythematosus","volume":"36","author":"Katkam","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.gene.2021.146027_b0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.gene.2021.146027_b0125","doi-asserted-by":"crossref","first-page":"e52298","DOI":"10.1371\/journal.pone.0052298","article-title":"Increased tumor necrosis factor (TNF)-\u03b1 and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo","volume":"7","author":"Laddha","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gene.2021.146027_b0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: Interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.gene.2021.146027_b0135","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2021.146027_b0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1468-3083.2012.04498.x","volume":"27","author":"Lee","year":"2013","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.gene.2021.146027_b0145","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4238\/2015.May.25.6","article-title":"Associations between TNF-\u03b1 polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: A meta-analysis","volume":"14","author":"Lee","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2021.146027_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.gene.2021.146027_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1122","article-title":"Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets","author":"Lu","year":"2020","journal-title":"Clin. Transl. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2021.146027_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00403-008-0904-8","article-title":"Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients","volume":"301","author":"Namian","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.gene.2021.146027_b0165","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.4238\/2015.December.16.30","article-title":"Meta-analysis of the TNF-\u03b1-308G\/A polymorphism and vitiligo risk","volume":"14","author":"Nie","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2021.146027_b0170","first-page":"1","article-title":"Genetic Association of TNF- Alpha Polymorphisms with Generalized Vitiligo in Jordanian Population","volume":"3","author":"Odeh","year":"2019","journal-title":"J Genet Disord Genet Med"},{"issue":"6","key":"10.1016\/j.gene.2021.146027_b0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1159\/000505544","article-title":"Association Analysis of Tumor Necrosis Factor Alpha Promoter Polymorphisms and Vitiligo Susceptibility in South Indian Tamils","volume":"236","author":"Rajendiran","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.gene.2021.146027_b0180","doi-asserted-by":"crossref","unstructured":"Saleh, N.F., Nabil, N., Bassiouny, D.A., Khorshied, M.M., 2014. Tumor necrosis factor a promotor polymorphism and nonsegmental vitiligo\u00a0: a molecular susceptibility marker in Egyptian women 109\u2013112. 10.1097\/01.EWX.0000443903.37427.6c.","DOI":"10.1097\/01.EWX.0000443903.37427.6c"},{"key":"10.1016\/j.gene.2021.146027_b0185","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3892\/etm.2012.508","article-title":"Tumor necrosis factor- \u03b1 -308G \/ A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population","volume":"3","author":"Salinas-santander","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.gene.2021.146027_b0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2249.2007.03564.x","article-title":"Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-\u03b1 levels in Asian Indians","volume":"151","author":"Sharma","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.gene.2021.146027_b0195","doi-asserted-by":"crossref","first-page":"155432","DOI":"10.1016\/j.cyto.2021.155432","article-title":"Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo","volume":"140","author":"Singh","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.gene.2021.146027_b0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of Vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol. Clin."},{"issue":"4","key":"10.1016\/j.gene.2021.146027_b0205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.humimm.2017.02.006","article-title":"Impaired NK cell functionality and increased TNF-\u03b1 production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis","volume":"78","author":"Thanapati","year":"2017","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.gene.2021.146027_b0210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjd.14016","article-title":"Tumour necrosis factor-\u03b1 inhibition can stabilize disease in progressive vitiligo","volume":"173","author":"Webb","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.gene.2021.146027_b0215","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/ijd.12866","article-title":"The association between tumor necrosis factor-\u03b1-308 G\/A polymorphism and risk for vitiligo: A meta-analysis","volume":"54","author":"Wu","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.gene.2021.146027_b0220","article-title":"Association of TNF-\u03b1-308G\/A, -238G\/A, -863C\/A, -1031T\/C, -857C\/T polymorphisms with periodontitis susceptibility: Evidence from a meta-analysis of 52 studies","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.gene.2021.146027_b0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00403-006-0664-2","article-title":"Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo","volume":"298","author":"Yazici","year":"2006","journal-title":"Arch. Dermatol. Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921006223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921006223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:47:18Z","timestamp":1759855638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111921006223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"alternative-id":["S0378111921006223"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2021.146027","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis for association of TNFA-308(G\u00a0>\u00a0A) SNP with vitiligo susceptibility","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2021.146027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146027"}}